Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Anti-Cancer Drugs|January 16, 2016
Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in JapanKenta Nio, Daijiro Higashi, Hozumi Kumagai, et al.
Oncology Letters|February 13, 2016
Intraluminal superior vena cava metastasis from adenosquamous carcinoma of the duodenum: A case reportKotoe Takayoshi, Hiroshi Ariyama, Shingo Tamura, et al.
Molecular and Clinical Oncology|May 19, 2017
Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberansKenji Tsuchihashi, Hitoshi Kusaba, Yuichi Yamada, et al.
Molecular and Clinical Oncology|January 27, 2017
Cardiac metastasis of squamous cell carcinoma of the thyroid gland with severe disseminated intravascular coagulation: A case reportTomoyasu Yoshihiro, Kenji Tsuchihashi, Hitoshi Kusaba, et al.
Cancer Science|August 25, 2018
Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancerMichitaka Nakano, Mamoru Ito, Risa Tanaka, et al.
Therapeutic Advances in Medical Oncology|April 29, 2026
Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study)Yasunori Kawaguchi, Kohei Hayashi, Mototsugu Shimokawa, et al.
Therapeutic Advances in Medical Oncology|February 24, 2025
Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa, et al.
BMC Cancer|May 27, 2026
Effect of biliary drainage and biliary tract infection in unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: a multicenter, prospective cohort study (NAPOLEON-2)Wataru Yoshioka, Tsuyoshi Shirakawa, Mototsugu Shimokawa, et al.
Asia-Pacific Journal of Clinical Oncology|November 4, 2025
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Older Versus Younger Patients With Unresectable Pancreatic Cancer: The Multicenter NAPOLEON-2 StudyAtsuko Kakihara, Shigeyuki Takeshita, Mototsugu Shimokawa, et al.
BMC Cancer|October 22, 2025
Impact of biliary drainage for unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: retrospective results from the NAPOLEON-2 studyKazuo Nishikawa, Taiga Otsuka, Mototsugu Shimokawa, et al.
Pageof 6